Welcome! If you have any pricing inquiries, please don't hesitate to reach out to us using the form on the left side. We'll respond to you promptly.
As a company specializing in advanced biomedical solutions, CD Formulation places a strong emphasis on innovation and research. Our expertise lies in designing and developing hydrogels with tailored properties optimized for applications and payloads. Through material selection, synthesis, and characterization capabilities, our formulation scientists engineer hydrogels to facilitate precise and sustained release of nucleic acids at desired sites.
Hydrogels are three-dimensional polymer networks that can absorb large amounts of water or biological fluids. They resemble natural tissues due to their high-water content and soft gel-like consistency. By entrapping therapeutic molecules within their cross-linked matrices, hydrogels can provide controlled release of payloads over extended periods. This makes them well-suited to various biomedical applications including drug delivery and tissue engineering.
Types of interactions between nucleic acids and hydrogel networks (Zhong R.; et al., 2023)
Custom polymer synthesis allows control of degradation rates via hydrolytic or enzymatic pathways.
Tuning of crosslink density, porosity, and water content to precisely modulate release kinetics.
In vitro/in vivo correlation studies to optimize multiple-week payload exposure profiles.
Engineering of temperature-, pH-, or ion-sensitive moieties directly within polymer backbones.
Incorporation of disease-relevant enzyme-cleavable substrates or affinity domains.
Multi-factorial designs combine degradation and trigger release mechanisms.
Comprehensive rheological, swelling and degradation assessments.
Real-time and endpoint analytical methods (PLC, spectroscopy) for profile release.
Cell-based assays and 3D bio-printing to simulate tissue-level release.
Conjugation or encapsulation of cell-specific antibodies, peptides or small molecules.
Evaluation of targeting efficiency and hydrogel biodistribution.
Development of targeted spheres, discs or other device-compatible formats.
Assessment of hydrogel biocompatibility, local and systemic toxicity.
Quantitative/qualitative in vivo analysis of transgene expression profiles.
Studies in disease models (cancer, inflammation, musculoskeletal) to demonstrate therapeutic effects.
Natural Polymers | Collagen, fibrin, alginate, chitosan, hyaluronic acid |
Synthetic Polymers | PEG, PVA, PEG-co-PVA, PEG acrylates |
Peptides | RGD, IKVAV, integrin-binding peptides |
Block Co-polymers | PCL-PEG, PLA-PEG |
Dendrimers | PAMAM, PPI |
Modified Polysaccharides | Methacrylated hyaluronic acid, chitosan |
Crosslinking Agents | Glutaraldehyde, genipin, carbodiimides, photoinitiators |
Physical Crosslinking |
|
Chemical Crosslinking |
|
Enzyme Crosslinking |
|
Self-Assembly |
|
Electrostatic Interaction |
|
Mixed Methods |
|
CD Formulation can customize hydrogel properties such as mechanical strength, porosity, degradation rate, and biocompatibility to ensure optimal performance. Contact us and let us help accelerate your hydrogel development process!
References